secwatch.observer — SEC 8-K summary
======================================

Issuer:     AVITA Medical, Inc. (RCEL)
CIK:        0001762303
Form:       8-K
Filed at:   2024-05-30T23:59:59+00:00
Accession:  0000950170-24-066656
Event type: regulatory
Sentiment:  positive
Materiality: 0.85
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

AVITA Medical receives FDA approval for RECELL GO next-gen skin harvesting device
--------------------------------------------------------------------------------

- FDA approved RECELL GO next-gen autologous cell harvesting device for thermal burn wounds and full-thickness skin defects.
- Device reduces training burden, improves OR workflow, and controls enzyme incubation for optimal cell yield; launch June 2024.
- Clinical benefits: uses less donor skin, reduces pain, speeds closure, cuts procedures, shortens hospital stays for burns <50% TBSA.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1762303/000095017024066656/0000950170-24-066656-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1762303/000095017024066656/rcel-20240529.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-066656

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer